Postpartum hemorrhage is a severe yet preventable complication following childbirth. Globally, PPH affects 14 million women annually, causing approximately 70,000 maternal deaths. In the Philippines, it is a significant contributor to the maternal mortality ratio of 114 deaths per 100,000 live births as of 2023. Dr. Esmeraldo Ilem, Medical Center Chief II of Dr. Jose Fabella Memorial Hospital, explains that PPH, often unpredictable, requires early detection and intervention to prevent fatal outcomes.
“The first hour post-childbirth is the golden hour for PPH,” emphasizes Dr. Ilem. Severe blood loss, defined as 1,000 mL or more, occurs predominantly within this period. Studies show 73 percent of major bleeding happens within the first 40 minutes. Early monitoring of vital signs—such as heart rate and blood pressure—can be life-saving.
Delays in treatment, especially in administering uterotonic medications to contract the uterus, elevate risks. Dr. Ilem explained that for every 5-minute delay, the odds of hypotension increase by 26 percent, and the need for blood transfusions rises by 34 percent. Innovative tools and approaches, however, are transforming PPH management.
One such method is Organon’s JADA System. The device is connected to a low-level vacuum source and inserted into the uterus. By using gentle suction, the device promotes uterine contraction, providing quick control and treatment of PPH.
Dr. Osama Omran, Consultant OBS & GYN at Al Qassimi Women and Children Hospital in United Arab Emirates (UAE), has successfully managed PPH cases with the JADA System. Since its introduction in early 2024, it has achieved a 100 percent success rate in controlling severe postpartum bleeding.
Two major studies—PEARLE and RUBY—underscore the device’s effectiveness. The PEARLE study demonstrated a 94 percent success rate in controlling bleeding, with a median time of 3 minutes. The RUBY study validated these findings in real-world settings, reinforcing the JADA System’s role as a vital tool in maternal care.
Dr. Ina Crisologo, Medical Lead for Asia Pacific at Organon, highlights how the JADA System optimizes public health funds by preventing costly complications such as hysterectomy, uterine ligation, blood transfusions, and extended ICU stays. “Investing in this device not only improves patient outcomes but ensures efficient use of healthcare resources,” she explains.
Organon’s unwavering commitment to women’s health drives innovations like the JADA System, offering hope to millions of mothers at risk of PPH. By focusing on early detection, timely intervention, and accessible solutions, Organon underscores its belief that no mother should die from giving birth.
